We use cookies for a better user experience. Read our Privacy Policy

I Agree

Hyperthermia Cancer Treatment Market

Hyperthermia Cancer Treatment Market (Device Type: Infrared Hyperthermia Devices, Ultrasound Hyperthermia Devices, Microwave Hyperthermia Devices, and Others; Treatment Method: Locoregional Method and Whole-body; Application: Breast Cancer, Liver Cancer, Soft Tissue Sarcoma, Head & Neck Tumors, Prostate Cancer, and Others; and End User: Hospitals & Specialty Clinics, Ambulatory Surgical Centers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

Rise in Investments in Telemedicine for Access to Cancer Care during COVID-19

Healthcare costs seem to have increased for cancer patients amid the ongoing coronavirus situation, since these patients are at the high risk of contracting the infection, owing to low immunity levels. This has created revenue opportunities for companies in the hyperthermia cancer treatment market, as clinicians have boosted their capabilities in telemedicine and other digital platforms to increase accessibility to patient care.

Hospitals and specialty clinics are increasing their investments in developing special screening departments for the evaluation of cancer patients with potential COVID-19 symptoms. Such trends are generating business streams in order to revive growth of the hyperthermia cancer treatment market. However, many clinics have limited and even excluded the amount of visitors that are at the low risk of COVID-19.

hyperthermia cancer treatment market segmentation

Request a sample to get extensive insights into the Hyperthermia Cancer Treatment Market

Scientists Address Undesired Crystalline Phases in Glass Ceramics for Hyperthermia Techniques

Companies in the hyperthermia cancer treatment market are increasing their R&D in new treatment options for patients. This has led to the emergence of glass ceramics for hyperthermia techniques, owing to their advantages of biocompatibility, bioactivity, and osteoproductivity. However, scientists are yet to explore ways to prevent the occurrence of undesired crystalline phases in the material. Companies are partnering with researchers and scientists to prevent the magnetite oxidation to hematite, which can emerge, while undergoing the heat treatment.

The hyperthermia cancer treatment market is slated to register a favorable CAGR of ~6% during the forecast period. This is evident since glass ceramics in hyperthermia techniques are capable of raising the temperature of cancerous tissues high enough to destroy it.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Deep Tissue Thermal Therapy Holds Promising Potentials in Breast Cancer Treatment

The hyperthermia cancer treatment market is predicted to reach US$ 266 Mn by the end of 2030. The deep tissue thermal therapy is gaining prominence in the cancer treatment space, especially among patients with breast cancer. The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC), U.S., is gaining recognition for its comprehensive and individualized thermal therapy works. This indicates that med-tech companies are unlocking growth opportunities in the U.S., since North America is anticipated to dictate the highest revenue share among all regions in the market. The deep tissue therapy is being combined with the proton therapy to improve medical outcomes.

hyperthermia cancer treatment market infographic

Stuck in a neck-to-neck competition with other brands? Request a custom report on Hyperthermia Cancer Treatment Market

Ultrasound Hyperthermia Devices Provide Quality Assurance for Treatment of Cancer Patients

The therapeutic application of heat is found to be effective in cancer treatment. Hence, med-tech companies in the hyperthermia cancer treatment market are increasing their production capacities in high quality heating equipment to enable precise thermal dosimetry. This has led to innovations in antennas and power delivery systems that provide adequate quality assurance for the treatment of cancer patients.

High intensity focused ultrasound (HIFU), nanoparticle heating, and scanned focused ultrasound (SFUS) techniques are broadening revenue streams for companies in the hyperthermia cancer treatment market. As such, ultrasound hyperthermia devices are predicted to dominate the second highest revenue among all device types in the market.

Strong R&D in Operating Principles of Internal Heating Techniques Improves Medical Outcomes

Combination treatments such as hyperthermia with chemotherapy via controlled localized heating can be achieved with the help of radiofrequency (RF) and microwave. Recent advancements in radiofrequency and microwave mediated hyperthermia include applicators that are most suitable for superficial hyperthermia. On the other hand, internal heating or deep hyperthermia is being combined with brachytherapy i.e. a needle-shaped antenna/electrode that can be implanted directly in the tissue or inserted via catheters.

The high variety in applicator designs for internal heating such as microwave antennas, capacitive-coupled RF catheter-based electrodes, and ultrasound systems are creating value grab opportunities for companies in the hyperthermia cancer treatment market. Med-tech companies are gaining a strong research in operating principles of internal heating techniques and other devices.

Analysts’ Viewpoint

Telemedicine and mobile apps are offering wellness and stress management resources to cancer patients amid the ongoing COVID-19 pandemic. Companies in the hyperthermia cancer treatment market are benefitting with the help of the deep tissue thermal therapy, owing to its non-invasive nature that omits the need of anesthesia. However, radiation dose weighting-based on clonogenic cell survival analysis alone may not be sufficient to predict treatment efficacy. Hence, companies in the hyperthermia cancer treatment market should increase their R&D in more sophisticated biological dose concepts based on spheroid data to improve patient outcomes. Glass ceramics are a breakthrough innovation in the hyperthermia cancer treatment that hold promising potentials with advancements in biomaterial R&D.

Hyperthermia Cancer Treatment Market: Overview

  • Hyperthermia is a form of therapy where heat is used to enhance effectiveness of radiation and chemotherapy, and to destroy tumors. Hyperthermia is most often used to treat tumors that are close to the surface of the body. In the hyperthermia treatment, the tumor area is heated to a temperature of 40 degree Celsius to 43 degree Celsius (104 degree Fahrenheit to 109 degree Fahrenheit) for approximately one hour.
  • Recently, several clinical trials showed that hyperthermia with radiation therapy and/or chemotherapy for the treatment of recurrent breast cancer, melanoma, head & neck cancer, prostate, cervix, and other sites of locally advanced or recurrent cancers provides additional benefits with lower side effects to destroy cancer cells
  • Different types of devices used for hyperthermia treatment includes infrared hyperthermia devices, ultrasound hyperthermia devices, microwave hyperthermia devices, and others
  • The global hyperthermia cancer treatment market has experienced significant growth in the last decade due to rise in prevalence of various types of cancer and favorable policies

Hyperthermia Cancer Treatment Market: Drivers

  • Rise in prevalence and incidence of cancers such as breast, liver, soft tissue sarcoma, head & neck tumors, prostate cancer, and others drives demand for hyperthermia cancer treatment. According to the National Cancer Institute (NIH), an estimated 1,806,590 cases are expected to be diagnosed in the U.S. in 2020, with prostate, lung, and colorectal cancer likely to account for 43% of the total cancer cases in men. More than 60% of the world’s new cancer cases occur in Africa, Asia, and Central and South America, and 70% of the total cancer deaths globally occur in these regions.
  • Increase in the geriatric population directly affects the global hyperthermia cancer treatment market. The population aged 65 years and above has higher cancer incidence and mortality rate than younger people. Around 60% of cancer conditions occur among the geriatric population, 10 to 11 times higher than in the younger population.

Market Segmentation: Hyperthermia Cancer Treatment Market

  • In terms of device type, the global hyperthermia cancer treatment market has been divided into infrared hyperthermia devices, ultrasound hyperthermia devices, microwave hyperthermia devices, and others. The microwave hyperthermia devices segment is projected to dominate the global hyperthermia cancer treatment market during the forecast period.
  • Based on treatment method, the global hyperthermia cancer treatment market has been bifurcated into locoregional and whole-body. The locoregional segment has been split into external & interstitial, intraluminal or endocavitary methods, continuous hyperthermic peritoneal perfusion (CHPP), and deep tissue & regional perfusion.
  • In terms of application, the global hyperthermia cancer treatment market has been classified into breast cancer, liver cancer, soft tissue sarcoma, head & neck tumors, prostate cancer, and others
  • Based on end user, the global hyperthermia cancer treatment market has been categorized into hospitals & specialty clinics, ambulatory surgical centers, and others. The hospitals & specialty clinics segment dominated the global hyperthermia cancer treatment market in terms of revenue in 2019.
  • Each of the segments has been analyzed in detail for market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights. The report provides current and expected revenue (US$ Mn) for each of these segments from 2018 to 2030, considering 2019 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2020 to 2030, along with market size estimations.

Regional Overview: Hyperthermia Cancer Treatment Market

  • In terms of region, the global hyperthermia cancer treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries and sub-regions.
  • The current and expected market revenue (US$ Mn) of these regional markets and their major countries have been provided in the report from 2018 to 2030, with their CAGRs from 2020 to 2030
  • The study also offers a list of recommendations, highlights, and useful insights of the global hyperthermia cancer treatment market, which would help new companies willing to enter the market and existing companies to increase market shares and in the decision-making process

Hyperthermia Cancer Treatment Market: Major Players

  • The hyperthermia cancer treatment market report concludes with the company profiles section, which includes key information about major players in the global hyperthermia cancer treatment market
  • Leading players analyzed in the hyperthermia cancer treatment market report include
    • Pyrexar Medical
    • Celsius42 GmbH
    • Hydrosun GmbH
    • Oncotherm Kft
    • Andromedic S.r.l.
    • Yamamoto Vinita Co., Ltd.
    • Chongqing Haifu Medical Technology Co., Ltd.
    • innoMedicus Ltd.
    • Gamida
    • RanD
  • Each of these players has been profiled in the hyperthermia cancer treatment market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments

Hyperthermia Cancer Treatment Market – Segmentation

TMR’s study on the global hyperthermia cancer treatment market includes information divided into five segments: device type, treatment method, application, end user, and region. Changing industry trends and other crucial market dynamics associated with these segments of the global hyperthermia cancer treatment market are discussed in detail.

Device Type

  • Infrared Hyperthermia Devices
  • Ultrasound Hyperthermia Devices
  • Microwave Hyperthermia Devices
  • Others
Treatment Method
  • Locoregional Method
    • External & Interstitial
    • Intraluminal or Endocavitary Methods
    • Continuous Hyperthermic Peritoneal Perfusion (CHPP)
    • Deep Tissue & Regional Perfusion
  • Whole-body
Application
  • Breast Cancer
  • Liver Cancer
  • Soft Tissue Sarcoma
  • Head & Neck Tumors
  • Prostate Cancer
  • Others
End User
  • Hospitals & Specialty Clinics
  • Ambulatory Surgical Centers
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Hyperthermia Cancer Treatment Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of hyperthermia cancer treatment market?

Hyperthermia cancer treatment market to cross valuation of US$ 266 Mn by 2030

What is the anticipated CAGR of the hyperthermia cancer treatment market in the forecast period?

Hyperthermia cancer treatment market is projected to expand at a CAGR of ~6% from 2020 to 2030

What are the key driving factors for the growth of the hyperthermia cancer treatment market?

Hyperthermia cancer treatment market is driven by rise in prevalence and incidence of cancers

Which is the rising prominent segment in the hyperthermia cancer treatment market?

The microwave hyperthermia devices segment is projected to dominate the global hyperthermia cancer treatment market during the forecast period

Who are the key players in the global hyperthermia cancer treatment market?

Key players in the global hyperthermia cancer treatment market include Pyrexar Medical, Celsius42 GmbH, Hydrosun GmbH, Oncotherm Kft, Andromedic S.r.l.

1. Preface

    1.1. Report Scope and Market Segmentation

    1.2. Research Highlights

2. Assumptions and Research Methodology

    2.1. Assumptions and Acronyms Used

    2.2. Research Methodology

3. Executive Summary

4. Market Overview

    4.1. Introduction

    4.2. Market Dynamics

        4.2.1. Drivers

        4.2.2. Restraints

        4.2.3. Opportunity

    4.3. Global Hyperthermia Cancer Treatment Market Forecast

    4.4. Global Hyperthermia Cancer Treatment Market Outlook

5. Market Outlook

    5.1. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

    5.2. Epidemiology of Cancer Globally/Country

    5.3. Reimbursement Scenario 

    5.4. Regulatory Scenario 

    5.5. Overview on Combination Cancer Treatment Strategies along with Hyperthermia

6. Global Hyperthermia Cancer Treatment Market Analysis, by Device Type

    6.1. Introduction

    6.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type

    6.3. Global Hyperthermia Cancer Treatment Market Forecast, by Device Type

        6.3.1. Infrared Hyperthermia Devices

        6.3.2. Ultrasound Hyperthermia Devices

        6.3.3. Microwave Hyperthermia Devices

        6.3.4. Others

    6.4. Global Hyperthermia Cancer Treatment Market Analysis, by Device Type

7. Global Hyperthermia Cancer Treatment Market Analysis, by Treatment Method

    7.1. Introduction 

    7.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method

    7.3. Global Hyperthermia Cancer Treatment Market Forecast, by Treatment Method

        7.3.1. Locoregional

            7.3.1.1. External & Interstitial

            7.3.1.2. Intraluminal or Endocavitary Methods

            7.3.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)

            7.3.1.4. Deep Tissue & Regional Perfusion

        7.3.2. Whole-body

    7.4. Global Hyperthermia Cancer Treatment Market Analysis, by Treatment Method

8. Global Hyperthermia Cancer Treatment Market Analysis, by Application

    8.1. Introduction 

    8.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application

    8.3. Global Hyperthermia Cancer Treatment Market Forecast, by Application

        8.3.1. Breast Cancer

        8.3.2. Liver Cancer

        8.3.3. Soft Tissue Sarcoma

        8.3.4. Head & Neck Tumors

        8.3.5. Prostate Cancer

        8.3.6. Others

    8.4. Global Hyperthermia Cancer Treatment Market Analysis, by Application

9. Global Hyperthermia Cancer Treatment Market Analysis, by End-user

    9.1. Introduction

    9.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user

    9.3. Global Hyperthermia Cancer Treatment Market Forecast, by End-user

        9.3.1. Hospitals & Specialty Clinics

        9.3.2. Ambulatory Surgical Centers

        9.3.3. Others

    9.4. Global Hyperthermia Cancer Treatment Market Analysis, by End-user

10. Global Hyperthermia Cancer Treatment Market Analysis, by Region

    10.1. Global Hyperthermia Cancer Treatment Market Scenario, by Region/Country

    10.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Region

    10.3. Global Hyperthermia Cancer Treatment Market Forecast, by Region

        10.3.1. North America

        10.3.2. Europe

        10.3.3. Asia Pacific

        10.3.4. Latin America

        10.3.5. Middle East & Africa

11. North America Hyperthermia Cancer Treatment Market Analysis

    11.1. North America Hyperthermia Cancer Treatment Market Overview

    11.2. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country

    11.3. North America Hyperthermia Cancer Treatment Market Forecast, by Country

        11.3.1. U.S.

        11.3.2. Canada

    11.4. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type

    11.5. North America Hyperthermia Cancer Treatment Market Forecast, by Device Type

        11.5.1. Infrared Hyperthermia Devices

        11.5.2. Ultrasound Hyperthermia Devices

        11.5.3. Microwave Hyperthermia Devices

        11.5.4. Others

    11.6. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method

    11.7. North America Hyperthermia Cancer Treatment Market Forecast, by Treatment Method

        11.7.1. Locoregional

            11.7.1.1. External & Interstitial

            11.7.1.2. Intraluminal or Endocavitary Methods

            11.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)

            11.7.1.4. Deep Tissue & Regional Perfusion

        11.7.2. Whole-body

    11.8. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application

    11.9. North America Hyperthermia Cancer Treatment Market Forecast, by Application

        11.9.1. Breast Cancer

        11.9.2. Liver Cancer

        11.9.3. Soft Tissue Sarcoma

        11.9.4. Head & Neck Tumors

        11.9.5. Prostate Cancer

        11.9.6. Others

    11.10. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user

    11.11. North America Hyperthermia Cancer Treatment Market Forecast, by End-user

        11.11.1. Hospitals & Specialty Clinics

        11.11.2. Ambulatory Surgical Centers

        11.11.3. Others 

12. Europe Hyperthermia Cancer Treatment Market Analysis

    12.1. Europe Hyperthermia Cancer Treatment Market Overview

    12.2. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region

    12.3. Europe Hyperthermia Cancer Treatment Market Forecast, by Country/Sub-region

        12.3.1. Germany

        12.3.2. France

        12.3.3. U.K.

        12.3.4. Italy

        12.3.5. Spain

        12.3.6. Rest of Europe

    12.4. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type

    12.5. Europe Hyperthermia Cancer Treatment Market Forecast, by Device Type

        12.5.1. Infrared Hyperthermia Devices

        12.5.2. Ultrasound Hyperthermia Devices

        12.5.3. Microwave Hyperthermia Devices

        12.5.4. Others

    12.6. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method

    12.7. Europe Hyperthermia Cancer Treatment Market Forecast, by Treatment Method

        12.7.1. Locoregional

            12.7.1.1. External & Interstitial

            12.7.1.2. Intraluminal or Endocavitary Methods

            12.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)

            12.7.1.4. Deep Tissue & Regional Perfusion

        12.7.2. Whole-body

    12.8. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application

    12.9. Europe Hyperthermia Cancer Treatment Market Forecast, by Application

        12.9.1. Breast Cancer

        12.9.2. Liver Cancer

        12.9.3. Soft Tissue Sarcoma

        12.9.4. Head & Neck Tumors

        12.9.5. Prostate Cancer

        12.9.6. Others

    12.10. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user

    12.11. Europe Hyperthermia Cancer Treatment Market Forecast, by End-user

        12.11.1. Hospitals & Specialty Clinics

        12.11.2. Ambulatory Surgical Centers

        12.11.3. Others 

13. Asia Pacific Hyperthermia Cancer Treatment Market Analysis

    13.1. Asia Pacific Hyperthermia Cancer Treatment Market Overview

    13.2. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region

    13.3. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by Country/Sub-region

        13.3.1. Japan

        13.3.2. China

        13.3.3. India

        13.3.4. Australia & New Zealand

        13.3.5. Rest of Asia Pacific

    13.4. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type

    13.5. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by Device Type

        13.5.1. Infrared Hyperthermia Devices

        13.5.2. Ultrasound Hyperthermia Devices

        13.5.3. Microwave Hyperthermia Devices

        13.5.4. Others

    13.6. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method

    13.7. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by Treatment Method

        13.7.1. Locoregional

            13.7.1.1. External & Interstitial

            13.7.1.2. Intraluminal or Endocavitary Methods

            13.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)

            13.7.1.4. Deep Tissue & Regional Perfusion

        13.7.2. Whole-body

    13.8. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application

    13.9. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by Application

        13.9.1. Breast Cancer

        13.9.2. Liver Cancer

        13.9.3. Soft Tissue Sarcoma

        13.9.4. Head & Neck Tumors

        13.9.5. Prostate Cancer

        13.9.6. Others

    13.10. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user

    13.11. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by End-user

        13.11.1. Hospitals & Specialty Clinics

        13.11.2. Ambulatory Surgical Centers

        13.11.3. Others 

14. Latin America Hyperthermia Cancer Treatment Market Analysis

    14.1. Latin America Hyperthermia Cancer Treatment Market Overview

    14.2. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region

    14.3. Latin America Hyperthermia Cancer Treatment Market Forecast, by Country/Sub-region

        14.3.1. Brazil

        14.3.2. Mexico

        14.3.3. Rest of Latin America

    14.4. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type

    14.5. Latin America Hyperthermia Cancer Treatment Market Forecast, by Device Type

        14.5.1. Infrared Hyperthermia Devices

        14.5.2. Ultrasound Hyperthermia Devices

        14.5.3. Microwave Hyperthermia Devices

        14.5.4. Others

    14.6. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method

    14.7. Latin America Hyperthermia Cancer Treatment Market Forecast, by Treatment Method

        14.7.1. Locoregional

            14.7.1.1. External & Interstitial

            14.7.1.2. Intraluminal or Endocavitary Methods

            14.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)

            14.7.1.4. Deep Tissue & Regional Perfusion

        14.7.2. Whole-body

    14.8. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application

    14.9. Latin America Hyperthermia Cancer Treatment Market Forecast, by Application

        14.9.1. Breast Cancer

        14.9.2. Liver Cancer

        14.9.3. Soft Tissue Sarcoma

        14.9.4. Head & Neck Tumors

        14.9.5. Prostate Cancer

        14.9.6. Others

    14.10. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user

    14.11. Latin America Hyperthermia Cancer Treatment Market Forecast, by End-user

        14.11.1. Hospitals & Specialty Clinics

        14.11.2. Ambulatory Surgical Centers

        14.11.3. Others

15. Middle East & Africa Hyperthermia Cancer Treatment Market Analysis

    15.1. Middle East & Africa Hyperthermia Cancer Treatment Market Overview

    15.2. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region

    15.3. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by Country/Sub-region

        15.3.1. GCC Countries

        15.3.2. South Africa

        15.3.3. Rest of Middle East & Africa

    15.4. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type

    15.5. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by Device Type

        15.5.1. Infrared Hyperthermia Devices

        15.5.2. Ultrasound Hyperthermia Devices

        15.5.3. Microwave Hyperthermia Devices

        15.5.4. Others

    15.6. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method

    15.7. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by Treatment Method

        15.7.1. Locoregional

            15.7.1.1. External & Interstitial

            15.7.1.2. Intraluminal or Endocavitary Methods

            15.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)

            15.7.1.4. Deep Tissue & Regional Perfusion

        15.7.2. Whole-body

    15.8. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application

    15.9. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by Application

        15.9.1. Breast Cancer

        15.9.2. Liver Cancer

        15.9.3. Soft Tissue Sarcoma

        15.9.4. Head & Neck Tumors

        15.9.5. Prostate Cancer

        15.9.6. Others

    15.10. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user

    15.11. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by End-user

        15.11.1. Hospitals & Specialty Clinics

        15.11.2. Ambulatory Surgical Centers

        15.11.3. Others

16. Competition Landscape

    16.1. Competition Matrix

    16.2. Company Profiles

        16.2.1. Pyrexar Medical

            16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.1.2. Product Portfolio

            16.2.1.3. SWOT Analysis

            16.2.1.4. Strategic Overview

        16.2.2. Celsius42 GmbH

            16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.2.2. Product Portfolio

            16.2.2.3. SWOT Analysis

            16.2.2.4. Strategic Overview

        16.2.3. Hydrosun GmbH

            16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.3.2. Product Portfolio

            16.2.3.3. SWOT Analysis

            16.2.3.4. Strategic Overview

        16.2.4. Oncotherm Kft

            16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.4.2. Product Portfolio

            16.2.4.3. SWOT Analysis

            16.2.4.4. Strategic Overview

        16.2.5. Andromedic S.r.l.

            16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.5.2. Product Portfolio

            16.2.5.3. SWOT Analysis

            16.2.5.4. Strategic Overview

        16.2.6. Yamamoto Vinita Co., Ltd.

            16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.6.2. Product Portfolio

            16.2.6.3. SWOT Analysis

            16.2.6.4. Strategic Overview

        16.2.7. Chongqing Haifu Medical Technology Co., Ltd

            16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.7.2. Product Portfolio

            16.2.7.3. SWOT Analysis

            16.2.7.4. Strategic Overview

        16.2.8. innoMedicus Ltd.

            16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.8.2. Product Portfolio

            16.2.8.3. SWOT Analysis

            16.2.8.4. Strategic Overview

        16.2.9. Gamida

            16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.9.2. Product Portfolio

            16.2.9.3. SWOT Analysis

            16.2.9.4. Strategic Overview

        16.2.10. RanD.

            16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.10.2. Product Portfolio

            16.2.10.3. SWOT Analysis

            16.2.10.4. Strategic Overview

List of Tables

Table 01: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device Type, 2018–2030

Table 02: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2018–2030

Table 03: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional Method, 2018–2030

Table 04: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 05: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 06: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 07: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 08: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device Type, 2018–2030

Table 09: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2018–2030

Table 10: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional, 2018–2030

Table 11: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 12: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 13: Europe Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 14: Europe Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device Type, 2018–2030

Table 15: Europe Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2018–2030

Table 16: Europe Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional Method, 2018–2030

Table 17: Europe Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 18: Europe Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 19: Asia Pacific Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 20: Asia Pacific Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device Type, 2018–2030

Table 21: Asia Pacific Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2018–2030

Table 22: Asia Pacific Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional, 2018–2030

Table 23: Asia Pacific Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 24: Asia Pacific Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 25: Latin America Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 26: Latin America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device Type, 2018–2030

Table 27: Latin America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2018–2030

Table 28: Latin America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional Method, 2018–2030

Table 29: Latin America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 30: Latin America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 31: Middle East & Africa Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 32: Middle East & Africa Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device Type, 2018–2030

Table 33: Middle East & Africa Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2018–2030

Table 34: Middle East & Africa Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional Method, 2018–2030

Table 35: Middle East & Africa Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 36: Middle East & Africa Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End-user, 2018–2030

List of Figures

Figure 01: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, 2018–2030

Figure 02: Global Hyperthermia Cancer Treatment Market Value Share, by Device Type, 2019

Figure 03: Global Hyperthermia Cancer Treatment Market Value Share, by Treatment Method, 2019

Figure 04: Global Hyperthermia Cancer Treatment Market Value Share, by Application, 2019

Figure 05: Global Hyperthermia Cancer Treatment Market Value Share, by End-user, 2019

Figure 06: Global Hyperthermia Cancer Treatment Market Value Share, by Region, 2019

Figure 07: Global New Cancer Cases & Deaths, 2017 

Figure 08: Incidence of Breast Cancer, by Country

Figure 09: Prevalence of Breast Cancer, by Country

Figure 10: Global Hyperthermia Cancer Treatment Market Value Share Analysis, by Device Type, 2019 and 2030

Figure 11: Global Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Device Type, 2020–2030

Figure 12: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Infrared Hyperthermia Devices, 2018–2030

Figure 13: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Ultrasound Hyperthermia Devices, 2018–2030

Figure 14: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Microwave Hyperthermia Devices, 2018–2030

Figure 15: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Others, 2018–2030

Figure 16: Global Hyperthermia Cancer Treatment Market Value Share Analysis, by Treatment Method, 2019 and 2030

Figure 17: Global Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Treatment Method, 2020–2030

Figure 18: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Locoregional, 2018–2030

Figure 19: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Whole-Body, 2018–2030

Figure 20: Global Hyperthermia Cancer Treatment Market Value Share Analysis, by Application, 2019 and 2030

Figure 21: Global Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Application, 2020–2030

Figure 22: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Breast Cancer, 2018–2030

Figure 23: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Liver Cancer, 2018–2030

Figure 24: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Soft Tissue Sarcoma, 2018–2030

Figure 25: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Head & Neck Tumors, 2018–2030

Figure 26: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Prostate Cancer, 2018–2030

Figure 27: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Others, 2018–2030

Figure 28: Global Hyperthermia Cancer Treatment Market Value Share Analysis, by End-user, 2019 and 2030

Figure 29: Global Hyperthermia Cancer Treatment Market Attractiveness, by End-user, 2020–2030

Figure 30: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Hospitals & Specialty Clinics, 2018–2030

Figure 31: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Ambulatory Surgical Centers, 2018–2030

Figure 32: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Standalone Devices, 2018–2030

Figure 33: Global Hyperthermia Cancer Treatment Market Value Share Analysis, by Region, 2019 and 2030

Figure 34: Global Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Region

Figure 35: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 36: North America Hyperthermia Cancer Treatment Market Value Share (%), by Country, 2019 and 2030

Figure 37: North America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Country, 2020–2030

Figure 38: North America Hyperthermia Cancer Treatment Market Value Share Analysis, by Device Type, 2019 and 2030

Figure 39: North America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Device Type, 2020–2030

Figure 40: North America Hyperthermia Cancer Treatment Market Value Share Analysis, by Treatment Method, 2019 and 2030

Figure 41: North America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Treatment Method, 2020–203041

Figure 42: North America Hyperthermia Cancer Treatment Market Value Share Analysis, by Application, 2019 and 2030

Figure 43: North America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Application, 2020–2030

Figure 44: North America Hyperthermia Cancer Treatment Market Value Share Analysis, by End-user, 2019 and 2030

Figure 45: North America Hyperthermia Cancer Treatment Market Attractiveness, by End-user, 2020–2030

Figure 46: Europe Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 47: Europe Hyperthermia Cancer Treatment Market Value Share (%), by Country/Sub-region, 2019 and 2030

Figure 48: Europe Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 49: Europe Hyperthermia Cancer Treatment Market Value Share Analysis, by Device Type, 2019 and 2030

Figure 50: Europe Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Device Type, 2020–2030

Figure 51: Europe Hyperthermia Cancer Treatment Market Value Share Analysis, by Treatment Method, 2019 and 2030

Figure 52: Europe Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Treatment Method, 2020–2030

Figure 53: Europe Hyperthermia Cancer Treatment Market Value Share Analysis, by Application, 2019 and 2030

Figure 54: Europe Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Application, 2020–2030

Figure 55: Europe Hyperthermia Cancer Treatment Market Value Share Analysis, by End-user, 2019 and 2030

Figure 56: Europe Hyperthermia Cancer Treatment Market Attractiveness Analysis, by End-user, 2020–2030

Figure 57: Asia Pacific Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 58: Asia Pacific Hyperthermia Cancer Treatment Market Value Share (%), by Country/Sub-region, 2019 and 2030

Figure 59: Asia Pacific Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 60: Asia Pacific Hyperthermia Cancer Treatment Market Value Share Analysis, by Device Type, 2019 and 2030

Figure 61: Asia Pacific Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Device Type, 2020–2030

Figure 62: Asia Pacific Hyperthermia Cancer Treatment Market Value Share Analysis, by Treatment Method, 2019 and 2030

Figure 63: Asia Pacific Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Treatment Method, 2020–2030

Figure 64: Asia Pacific Hyperthermia Cancer Treatment Market Value Share Analysis, by Application, 2019 and 2030

Figure 65: Asia Pacific Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Application, 2020–2030

Figure 66: Asia Pacific Hyperthermia Cancer Treatment Market Value Share Analysis, by End-user, 2019 and 2030

Figure 67: Asia Pacific Hyperthermia Cancer Treatment Market Attractiveness Analysis, by End-user, 2020–2030

Figure 68: Latin America Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 69: Latin America Hyperthermia Cancer Treatment Market Value Share (%), by Country/Sub-region, 2019 and 2030

Figure 70: Latin America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 71: Latin America Hyperthermia Cancer Treatment Market Value Share Analysis, by Device Type, 2019 and 2030

Figure 72: Latin America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Device Type, 2020–2030

Figure 73: Latin America Hyperthermia Cancer Treatment Market Value Share Analysis, by Treatment Method, 2019 and 2030

Figure 74: Latin America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Treatment Method, 2020–2030

Figure 75: Latin America Hyperthermia Cancer Treatment Market Value Share Analysis, by Application, 2019 and 2030

Figure 76: Latin America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Application, 2020–2030

Figure 77: Latin America Hyperthermia Cancer Treatment Market Value Share Analysis, by End-user, 2019 and 2030

Figure 78: Latin America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by End-user, 2020–2030

Figure 79: Middle East & Africa Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 80: Middle East & Africa Hyperthermia Cancer Treatment Market Value Share (%), by Country/Sub-region, 2019 and 2030

Figure 81: Middle East & Africa Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 82: Middle East & Africa Hyperthermia Cancer Treatment Market Value Share Analysis, by Device Type, 2019 and 2030

Figure 83: Middle East & Africa Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Device Type, 2020–2030

Figure 84: Middle East & Africa Hyperthermia Cancer Treatment Market Value Share Analysis, by Treatment Method, 2019 and 2030

Figure 85: Middle East & Africa Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Treatment Method, 2020–2030

Figure 86: Middle East & Africa Hyperthermia Cancer Treatment Market Value Share Analysis, by Application, 2019 and 2030

Figure 87: Middle East & Africa Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Application, 2020–2030

Figure 88: Middle East & Africa Hyperthermia Cancer Treatment Market Value Share Analysis, by End-user, 2019 and 2030

Figure 89: Middle East & Africa Hyperthermia Cancer Treatment Market Attractiveness Analysis, by End-user, 2020–2030

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

463

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved